The Skin Prep Study
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Nov 10, 2011
Trial Information
Current as of October 24, 2025
Completed
Keywords
ClinConnect Summary
RESEARCH DESIGN AND METHODS
This will be a randomized controlled clinical trial aimed at determining the comparative effectiveness of chlorhexidine-alcohol and iodine-alcohol preoperative skin preparation for preventing surgical site infection at cesarean section.
The investigators will use broad inclusion criteria and analyze all the main outcomes by the intent-to-treat principle. This approach will allow a more conservative estimate of differences between groups and allow a better estimate of effectiveness and public health implications of practice change rather than a pure estimate of ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women undergoing cesarean delivery at Barnes-Jewish Hospital.
- Exclusion Criteria:
- • Inability to obtain consent; allergy to chlorhexidine, alcohol, iodine, shellfish; and evidence of infection adjacent to operative site.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Methodius G Tuuli, MD, MPH
Principal Investigator
Washington University School of Medicine
George Macones, MD, MSCE
Study Chair
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials